Verastem reported $18.67M in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
AbbVie USD 16.99B 1.99B Jun/2026
Alaunos Therapeutics USD 2K 2K Mar/2025
AstraZeneca USD 15.38B 90M Jun/2026
Curis USD 1.14M 1.41M Dec/2025
Cytokinetics USD 19.35M 1.59M Mar/2026
Gilead Sciences USD 7B 930M Mar/2026
Incyte USD 1.67B 400M Jun/2026
Laboratory Of America USD 3.73B 190M Jun/2026
Novartis USD 14.41B 1.3B Jun/2026
Pfizer USD 15.03B 530M Jun/2026
Roche Holding CHF 30.36B 14.71B Jun/2026
TG Therapeutics USD 240.34M 45.54M Jun/2026
Verastem USD 18.67M 1.14M Mar/2026